DHR Health Earns an ‘A’ Hospital Safety Grade

Translate to Spanish or other 102 languages!

DHR Health is once again delighted to announce its “A” Hospital Safety Grade from The Leapfrog Group, an independent national nonprofit watchdog focused on patient safety. This grade for Fall 2025 is a testament to DHR Health’s commitment to patient safety and quality care. DHR Health previously received an “A” for Spring 2025. Courtesy image
DHR Health is once again delighted to announce its “A” Hospital Safety Grade from The Leapfrog Group, an independent national nonprofit watchdog focused on patient safety. This grade for Fall 2025 is a testament to DHR Health’s commitment to patient safety and quality care. DHR Health previously received an “A” for Spring 2025. Courtesy image
- Advertisement -

EDINBURG, Texas – DHR Health is once again delighted to announce its “A” Hospital Safety Grade from The Leapfrog Group, an independent national nonprofit watchdog focused on patient safety. This grade for Fall 2025 is a testament to DHR Health’s commitment to patient safety and quality care. DHR Health previously received an “A” for Spring 2025.

Leapfrog assigns an “A,” “B,” “C,” “D” or “F” grade to general hospitals across the country based on over 30 measures of errors, accidents, injuries and infections as well as the systems hospitals have in place to prevent them.

“This Leapfrog ‘A’ belongs to every member of the DHR Health family. I am proud of our employees and physicians who continue to lead with compassion and dedication, ensuring our patients receive the safest, highest-quality care possible. This achievement reflects the care and commitment our teams show every day to the patients and community we serve. It highlights the shared purpose that connects everyone at DHR Health,” said Dr. Manish Singh, DHR Health chief executive officer.

- Advertisement -

Marissa Castaneda, DHR Health senior executive vice president thanked every member of the DHR Health family for helping the organization achieve this goal. “This achievement reflects our dedication as a team. This outstanding accomplishment belongs to every member of our DHR Health family.”

The Leapfrog Hospital Safety Grade stands as the only hospital ratings program focused solely on preventable medical errors, infections and injuries that kill more than 500 patients a day in the United States. This program is peer-reviewed, fully transparent and free to the public. Grades are updated twice annually, in the fall and spring.

To explore full grade details and to find valuable tips for staying safe in the hospital, visit HospitalSafetyGrade.org. Connect with The Leapfrog Group on Twitter, Facebook, LinkedIn and Instagram and stay informed through The Leapfrog Group newsletter.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recognizes November as “National Hospice and Palliative Care” Month

DHR Health is pleased to recognize November as “National Hospice and Palliative Care Month.”  As we highlight National Hospice and Palliative Care Month, let us remember that healthcare is not solely about treating diseases but also about care for people at end of life.

STHS Heart Earns Healthgrades Five-Star Rating for Pacemaker Procedures

Healthgrades, the leading online resource for information about physicians and hospitals, has named STHS Heart a Five-Star Recipient for Pacemaker Procedures in 2027 for the second consecutive year, recognizing the facility's superior clinical outcomes and commitment to patient care.

AMA Advises Patients to Check with Doctors on Web Advice

The internet offers no shortage of health advice. But with misleading medical claims spread across social media, search engines, and AI platforms, finding trustworthy answers can be a challenge. 

FDA Authorizes Focused Ultrasound Treatment for Varicose Veins

Theraclion has announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for its Sonovein device to treat superficial venous reflux in great saphenous veins (GSV), the main cause of varicose veins. This is the first noninvasive focused ultrasound platform to treat varicose veins, which affect approximately one third of adults.
- Advertisement -